[go: up one dir, main page]

MX9710075A - Melatonin agonists for treating benign prostatic hyperplasia. - Google Patents

Melatonin agonists for treating benign prostatic hyperplasia.

Info

Publication number
MX9710075A
MX9710075A MX9710075A MX9710075A MX9710075A MX 9710075 A MX9710075 A MX 9710075A MX 9710075 A MX9710075 A MX 9710075A MX 9710075 A MX9710075 A MX 9710075A MX 9710075 A MX9710075 A MX 9710075A
Authority
MX
Mexico
Prior art keywords
benign prostatic
prostatic hyperplasia
melatonin agonists
treating benign
agonists
Prior art date
Application number
MX9710075A
Other languages
Spanish (es)
Other versions
MXPA97010075A (en
Inventor
David Oakley Clarke
William Henry Jordan
Lisa Ann Shipley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX9710075A publication Critical patent/MX9710075A/en
Publication of MXPA97010075A publication Critical patent/MXPA97010075A/en

Links

Landscapes

  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a method for the treatment of benign prostatic hyperplasia using various melatonin agonists.
MXPA/A/1997/010075A 1995-06-14 1997-12-11 Melatonine agonists for the treatment in prostatic hyperplasia beni MXPA97010075A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61013595A 1995-06-14 1995-06-14
US000203 1995-06-14

Publications (2)

Publication Number Publication Date
MX9710075A true MX9710075A (en) 1998-03-29
MXPA97010075A MXPA97010075A (en) 1998-10-15

Family

ID=

Similar Documents

Publication Publication Date Title
EA200000220A1 (en) COMBINATION OF TYROSINKINASE INHIBITOR AND CHEMICAL STERILIZATION FOR TREATMENT OF PROSTATE GLAND
AU6393896A (en) Method for treating benign prostatic hyperplasia with thermal therapy
GB2344532A (en) Electromagnetic radiation therapy
DE69830072D1 (en) RADIOACTIVE COMPOSITIONS FOR THE TREATMENT OF PROSTATE TUMORS
MX9707570A (en) USE OF 'alpha'1L AGONISTS IN THE TREATMENT OF INCONTINENCE.
MY112949A (en) Benzo-thiaphene estrogen agonists to treat prostatic hyperplasia
HK1029922A1 (en) Angiostatic agents and compositions for treating glc1a glaucoma
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
EP0646007A4 (en)
ZA969925B (en) Composition for treating stains on laundry items and methods of treatment.
EP1743656A3 (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
NO974153D0 (en) Apparatus for treating curved surfaces
IL105240A0 (en) Method and pharmaceutical formulation for treating benign prostatic hyperplasia
ZA982819B (en) Treatment or prophylaxis of prostatic cancer and benign prostatic hyperplasia with selective estrogn receptor modulators.
NO975838L (en) Melatonin agonists for the treatment of benign prostatic hyperplasia
MX9710075A (en) Melatonin agonists for treating benign prostatic hyperplasia.
NO973366L (en) Procedure for the treatment of multiple sclerosis
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
EP0633781A4 (en) Compositions and methods for treating benign prostatic hypertrophy.
IL130642A0 (en) N-(pyridinylamino)isoindolines and related compounds
ZA962141B (en) Treatment and prevention of prostatic cancer.
NO990436L (en) Procedure for the treatment of bipolar disorder
ZA922010B (en) Improved method of treatment for benign prostatic hyperplasia
AUPO410796A0 (en) Method of treating benign prostatic hyperplasia
GB9810895D0 (en) Combination therapy for the treatment of benign prostatic hyperplasia